Methylmalonic acid test · Normal B12

Methylmalonic Acid Test: When a Normal B12 Is Not Enough

A methylmalonic acid test shows whether B12 is doing its job inside your cells, not just how much is floating in your blood. When B12 fails at that job, methylmalonic acid backs up, so the test can flag a shortfall behind a normal serum B12.

Your B12 came back normal. In an Oxford brain-imaging study, so did the results of the people losing brain volume fastest, and the methylmalonic acid test is one way to see what that number leaves out.

The video above, Your Lab Says Normal. Your Brain Is Shrinking., carries a warning most people never hear at a physical: a serum B12 inside the reference range does not prove your cells are getting enough. The methylmalonic acid test asks a different question. Instead of counting how much B12 is floating in your blood, it looks for a chemical backlog that builds up when B12 is failing at its job inside the cell.

Dr. Padda spent years telling people with prediabetes that an A1C that was “not too bad” was fine. He was wrong, and a B12 in the normal range invites exactly the same shrug. It deserves the same second look.

Can you be low in B12 with a normal B12 level?

A laboratory range is drawn by testing a big group of people presumed healthy and labeling the middle of their results as normal. Nobody checks whether that group was well nourished first. B12 is made by bacteria and comes to people almost entirely from animal foods, so a population that eats fewer of them pulls its own range down, and the report keeps printing the word normal. The range tells you where the crowd stands. It does not tell you where health begins.

Researchers at Oxford put that to the test in 107 cognitively normal adults aged 61 to 87, scanning their brains every year for five years. Not one was deficient by the usual laboratory cutoff. Even so, people in the bottom third of B12, below 308 pmol/L, had about six times the odds of landing in the group losing brain volume fastest. A larger cohort of 501 older adults in Stockholm later pointed the same way: higher B12 went with slower shrinkage, and higher homocysteine went with faster.

What does a methylmalonic acid test measure?

Only two enzymes in the human body use B12. When one of them stalls, methylmalonic acid backs up. When the other stalls, homocysteine backs up. That is why both are called functional markers. Serum B12 counts the inventory on the shelf; methylmalonic acid and homocysteine tell you whether the work got done. A third blood test, holotranscobalamin, measures the small active share of B12 that cells can take up. About 80% of the B12 a standard test counts is bound to a carrier protein that does not hand it to your tissues.

The gap between the shelf and the work is measurable. Among 548 surviving members of the original Framingham cohort, methylmalonic acid was markedly raised in 11.3%, and the authors concluded that many older people with normal serum levels were metabolically deficient. In a laboratory study of people with cognitive complaints, total serum B12 did little better than a coin toss at picking out deficiency, while holotranscobalamin did better, though still modestly.

Who is most likely to have a B12 shortfall with a normal level?

• Adults over 60. Freeing B12 from food takes stomach acid and intrinsic factor, and in older people trouble releasing B12 from food becomes the leading cause of deficiency.
• People taking metformin. In the Diabetes Prevention Program, low or borderline B12 reached 19.1% in the metformin group against 9.5% on placebo at five years.
• People on long-term acid suppression. In a large Kaiser Permanente study, two or more years of a proton pump inhibitor carried higher odds of a B12 deficiency diagnosis, though studies that pooled the data call the average effect small.
• People who eat few animal foods, whose intake starts low.

None of these is a reason to stop a medication. Each is a reason to know the number, and to know what the number leaves out.

Why can one B12 marker read alone mislead you?

VITACOG randomized 271 adults aged 70 and over with mild cognitive impairment to high-dose B vitamins or placebo. Over two years, whole-brain shrinkage on MRI ran 29.6% slower on the vitamins, and the benefit concentrated in people whose homocysteine was high at the start. Then the investigators sorted participants by blood omega-3 levels. In the top third, the vitamins slowed atrophy. In the bottom third, they had no significant effect.

That split was an analysis done after the trial, so it is a hypothesis with a mechanism, not a settled law. The mechanism is easy to picture. B vitamins run the assembly line that makes phosphatidylcholine for cell membranes and myelin, and omega-3 fats are among the parts that line installs. Run the line with no parts and nothing ships. The practice position is that the two are measured and treated as a pair. For your lab work, the lesson is sharper than it looks: a partner nutrient can decide whether the first one matters at all, so one marker read alone can steer you wrong.

The food supply produces both shortfalls at the same time. It delivers abundant calories while crowding out the animal foods that carry B12 and the fish that carries EPA and DHA, then floods the plate with competing omega-6 fats. A person can be overfed and underbuilt in one body, and neither shows on the scale. The pattern also runs into insulin resistance, because the drug most often handed to insulin-resistant patients is the one that lowers B12.

Where Measura fits, and where it does not

Measura [Cardiometabolic and Autonomic Health Analysis] exists to put numbers on what a routine visit skips. It takes measurements, sends every finding to your physician, and leaves diagnosis and treatment decisions with that physician. Blood markers are drawn through laboratory panels, and which markers go on the order is a decision you make with your physician. Asking by name for methylmalonic acid, homocysteine and holotranscobalamin next to serum B12 is a reasonable way to open that conversation.

A shortfall that has run quietly for years does not always announce itself, so two other measurements show what the rest of the system is doing. A cognitive assessment records a baseline for memory and thinking before anyone is in a position to call a change a diagnosis. Sudomotor testing measures sweat-gland function in the small nerve fibers of the hands and feet, and nerve health belongs in the same conversation: in the Diabetes Prevention Program, neuropathy was more common in metformin users whose B12 was low. Neither test measures B12. Each shows the terrain while the blood work answers the nutrient question.

What should you ask your doctor about B12 testing?

• Where does my B12 sit inside the range, not just whether it is flagged?
• Can we add methylmalonic acid and homocysteine, and holotranscobalamin if the laboratory offers it?
• Can my folate be read beside my B12? Folate can correct the blood count while a B12 shortfall keeps affecting nerves, which is why it helps to know B12 status before taking high-dose folate.
• What is my omega-3 index?
• Am I taking metformin or an acid suppressor, and when was my B12 last checked?

More ideas for that visit are on questions worth asking your doctor. The book companion for Chapter 5 of The Starved Brain lists every study and number behind these questions, and the next post in the series, on B12 in aging parents, follows the same shortfall into later life. Unmeasured is unmanaged, and a normal result should start a question rather than end one.

Frequently asked questions

What does a high methylmalonic acid result mean?

A raised methylmalonic acid level suggests B12 is not getting its work done inside your cells, even when the serum B12 number looks fine. It is one piece of evidence, not a diagnosis by itself. Your physician reads it with serum B12, holotranscobalamin, homocysteine, your medications and your history. For how a result fits into the full picture, see understanding your results.

Is a homocysteine test the same as a methylmalonic acid test?

No. Both rise when the B12 machinery stalls, but homocysteine also rises when folate runs short, so the two answer slightly different questions. Homocysteine carries its own weight: among 1,092 Framingham adults with a mean age of 76, levels above 14 µmol/L went with nearly double the Alzheimer’s risk. For what any single marker can and cannot show, read what a test result can tell you.

Can a normal B12 level still affect memory?

In the Oxford cohort, lower B12 inside the normal range was linked to faster brain shrinkage in people with no cognitive impairment. That is an association, not proof that B12 caused it, and the study was small. It is a strong reason to look at where your number sits and to record a memory baseline early. See memory and cognitive screening.

Does Measura run B12 blood work?

Blood markers at Measura are drawn through laboratory panels, and the markers on the order are chosen with your physician. Measura measures and sends findings to your physician; it does not treat deficiency or prescribe supplements. If you want to know which outside laboratory processes the samples, read which laboratory runs the blood work.

How often should B12 be checked if I take metformin?

No fixed schedule appears in the research summarized here, but the risk builds with time: in the Diabetes Prevention Program, each added year of metformin carried an odds ratio of 1.13 for low B12. That makes a repeat measurement a conversation worth having at regular visits. For how repeat testing is usually planned, see how often to repeat testing.

Is methylmalonic acid high or low in B12 deficiency?

High. When B12 fails at its job inside the cell, one of the two enzymes that depend on it stalls and methylmalonic acid backs up. That is why the test can flag a shortfall while serum B12 still reads normal. Among 548 surviving members of the original Framingham cohort, methylmalonic acid was markedly raised in 11.3%, and many older people with normal serum levels were metabolically deficient.

How are vitamin B12 and methylmalonic acid related?

Only two enzymes in the human body use B12. When one stalls, methylmalonic acid builds up; when the other stalls, homocysteine builds up. Serum B12 counts the inventory on the shelf, while methylmalonic acid shows whether the work got done. Holotranscobalamin adds a third view: the small active share of B12 that cells can actually take up.

What causes a B12 shortfall that raises methylmalonic acid?

The common routes are age, medication and diet. After 60, trouble releasing B12 from food becomes the leading cause of deficiency. In the Diabetes Prevention Program, low or borderline B12 reached 19.1% on metformin against 9.5% on placebo at five years. Long-term acid suppression and eating few animal foods also lower it. None of these is a reason to stop a medication.

References

• Vogiatzoglou, A., Refsum, H., Johnston, C., Smith, S. M., Bradley, K. M., de Jager, C., Budge, M. M., & Smith, A. D. (2008). Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology, 71(11), 826–832. https://doi.org/10.1212/01.wnl.0000325581.26991.f2
• Hooshmand, B., Mangialasche, F., Kalpouzos, G., Solomon, A., Kåreholt, I., Smith, A. D., Refsum, H., Wang, R., Mühlmann, M., Ertl-Wagner, B., Laukka, E. J., Bäckman, L., Fratiglioni, L., & Kivipelto, M. (2016). Association of vitamin B12, folate, and sulfur amino acids with brain magnetic resonance imaging measures in older adults: A longitudinal population-based study. JAMA Psychiatry, 73(6), 606–613. https://doi.org/10.1001/jamapsychiatry.2016.0274
• Herrmann, W., & Obeid, R. (2012). Cobalamin deficiency. Sub-Cellular Biochemistry, 56, 301–322. https://doi.org/10.1007/978-94-007-2199-9_16
• Lindenbaum, J., Rosenberg, I. H., Wilson, P. W., Stabler, S. P., & Allen, R. H. (1994). Prevalence of cobalamin deficiency in the Framingham elderly population. The American Journal of Clinical Nutrition, 60(1), 2–11. https://doi.org/10.1093/ajcn/60.1.2
• Murphy, M. J., Brandie, F., Ebare, M., Harrison, M., Dow, E., Bartlett, W. A., & Craig, D. (2021). Personalising laboratory medicine in the ‘real world’: Assessing clinical utility, by clinical indication, of serum total B12 and Active-B12 (holotranscobalamin) in the diagnosis of vitamin B12 deficiency. Annals of Clinical Biochemistry, 58(5), 445–451. https://doi.org/10.1177/00045632211003605
• Aroda, V. R., Edelstein, S. L., Goldberg, R. B., Knowler, W. C., Marcovina, S. M., Orchard, T. J., Bray, G. A., Schade, D. S., Temprosa, M. G., White, N. H., & Crandall, J. P., for the Diabetes Prevention Program Research Group (2016). Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. The Journal of Clinical Endocrinology & Metabolism, 101(4), 1754–1761. https://doi.org/10.1210/jc.2015-3754
• Smith, A. D., Smith, S. M., de Jager, C. A., Whitbread, P., Johnston, C., Agacinski, G., Oulhaj, A., Bradley, K. M., Jacoby, R., & Refsum, H. (2010). Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. PLoS ONE, 5(9), e12244. https://doi.org/10.1371/journal.pone.0012244
• Jernerén, F., Elshorbagy, A. K., Oulhaj, A., Smith, S. M., Refsum, H., & Smith, A. D. (2015). Brain atrophy in cognitively impaired elderly: The importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. The American Journal of Clinical Nutrition, 102(1), 215–221. https://doi.org/10.3945/ajcn.114.103283
• Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D’Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. The New England Journal of Medicine, 346(7), 476–483. https://doi.org/10.1056/NEJMoa011613
• Lam, J. R., Schneider, J. L., Zhao, W., & Corley, D. A. (2013). Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA, 310(22), 2435–2442. https://doi.org/10.1001/jama.2013.280490

Related reading

• Statins and Memory Loss: What to Measure Before Anyone Guesses
• B12 Deficiency in the Elderly: A Guide for Adult Children
• Laboratory Panels

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, medical director of Measura. Last reviewed September 12, 2026.